A61L12/145

Ophthalmic and contact lens solutions using bicine
10138384 · 2018-11-27 · ·

The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: ##STR00001## where R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are H or low molecular weight radicals, and R.sub.5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.

Ophthalmic contact lens solutions containing forms of vitamin B
10064410 · 2018-09-04 · ·

The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.

CATIONIC COMPOUNDS AND THEIR USE AS ANTIMYCOTIC AND ANTIMICROBIAL AGENTS

The invention relates to cationic compounds and their use as antimicrobial and antimycotic agents, in particular as disinfectants and preservatives in ophthalmic preparations.

OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING SIMPLE SACCHARIDES AS PRESERVATIVE ENHANCERS
20180146678 · 2018-05-31 ·

The present invention relates to an ophthalmic solution comprising 0.00001 to 10.0 weight percent of a simple saccharide, at least 0.00001 weight percent of a preservative, and not more than about 0.2 percent by weight chloride. The simple saccharide is chosen from the group consisting of: inositol; mannitol; sorbitol; sucrose; dextrose; glycerin; propylene glycol; ribose; triose; tetrose; erythrose; threose; pentose; arabinose; ribulose; xylose; xylulose; lyxose; hexose; allose; altrose; fructose; galactose; glucose; gulose; idose; mannose; sorbose; talose; tagatose; adlose; ketose; heptose; sedoheptulose; monosaccharides; disaccharides; sugar alcohols; xylitol; and polyol.

Minimizing biological lipid deposits on contact lenses

Method for minimizing the sorption of tear lipids on frequent replacement, or extended-wear, contact lenses, the method comprising (a) contacting the contact lens selected from the group consisting of senofilcon A, lotrafilcon A, lotrafilcon B, and comfilcon A B with a lens care solution for a period of at least three hours to minimize the accumulation of tear lipids on the contact lens. The lens care solution comprises 0.5 ppm to 10 ppm -[4-tris(2-hydroxyethyl)-ammonium chloride-2-butenyl]poly[1-dimethyl ammonium chloride-2-butenyl]--tris(2-hydroxyethyl) ammonium chloride; citrate, citric acid or a mixture thereof; and 0.005 wt. % to 0.05 wt. % hyaluronic acid. The method also includes (b) inserting the soaked contact lens into one's eye, and (c) repeating steps (a) and (b).

Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
09913474 · 2018-03-13 · ·

The present invention relates to an ophthalmic solution comprising 0.00001 to 10.0 weight percent of a simple saccharide, at least 0.00001 weight percent of a preservative, and not more than about 0.2 percent by weight chloride. The simple saccharide is chosen from the group consisting of: inositol; mannitol; sorbitol; sucrose; dextrose; glycerin; propylene glycol; ribose; triose; tetrose; erythrose; threose; pentose; arabinose; ribulose; xylose; xylulose; lyxose; hexose; allose; altrose; fructose; galactose; glucose; gulose; idose; mannose; sorbose; talose; tagatose; adlose; ketose; heptose; sedoheptulose; monosaccharides; disaccharides; sugar alcohols; xylitol; and polyol.

CONTACT LENS TREATING SOLUTION

A contact lens treating solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the contact lens treating solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the contact lens treating solution, of erythritol; (c) one or more nonionic surfactants; (d) sodium chloride, potassium chloride or any combination thereof; and (e) one or more buffers.

OPHTHALMIC AND CONTACT LENS SOLUTIONS USING BICINE
20170369719 · 2017-12-28 ·

The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula:

##STR00001##

where R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are H or low molecular weight radicals, and R.sub.5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.

Ophthalmic and contact lens solutions using carnitine
09783688 · 2017-10-10 · ·

The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: ##STR00001##
where R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are H or low molecular weight radicals, and R.sub.5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.

OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CARNITINE
20170233592 · 2017-08-17 ·

The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula:

##STR00001##

where R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are H or low molecular weight radicals, and R.sub.5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.